Vertex Pharmaceuticals
VRTX
#151
Rank
A$201.65 B
Marketcap
A$796.12
Share price
3.50%
Change (1 day)
22.28%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2026 (TTM): A$7.44 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are A$12.58 Billion. In 2025 the company made an earning of A$6.86 Billion, an increase over its 2024 earnings that were of A$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$7.44 B8.36%
2025 A$6.86 B1627.59%
2024 A$0.39 B-93.69%
2023 A$6.30 B3.19%
2022 A$6.10 B53.56%
2021 A$3.97 B-12.06%
2020 A$4.52 B118.45%
2019 A$2.07 B120.64%
2018 A$0.93 B1473.64%
2017 A$59.63 M197.6%
2016 A$20.03 M-102.97%
2015 -A$0.68 Billion-28.46%
2014 -A$0.95 Billion-51.5%
2013 -A$1.95 Billion-30584.68%
2012 A$6.37 M-95.47%
2011 A$0.14 B
2009 -A$0.85 Billion
2007 -A$0.59 Billion83.1%
2006 -A$0.33 Billion59.02%
2005 -A$0.21 Billion3.28%
2004 -A$0.2 Billion-38.16%
2003 -A$0.32 Billion
2000 -A$54.2 Million-20.38%
1999 -A$68.06 Million31.62%
1998 -A$51.71 Million91.05%
1997 -A$27.07 Million-36.24%
1996 -A$42.46 Million12.45%
1995 -A$37.75 Million27.4%
1994 -A$29.63 Million-1833.33%
1993 A$1.7 M-112.12%
1992 -A$14.11 Million175%
1991 -A$5.13 Million-12.2%
1990 -A$5.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.33 B 419.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$12.39 B 72.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$2.79 Billion-138.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.95 B 52.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.96 B 136.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-A$71.54 Million-101.00%๐Ÿ‡บ๐Ÿ‡ธ USA